Phase 2 N=8 Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
Purpura, Thrombocytopenic, Idiopathic
Primary: Free Hemoglobin — 13.057; 12.371 g/dL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=350 A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
Asthma
Primary: Final Dose-response Model for Trough Forced Expiratory Volume in One Second (FEV1) — 0.0363; -0.97; 0.00371; 0.149 unitless
Phase 2 N=24 PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation
Multiple Myeloma
Primary: Area Under the Curve (0-t) — 376577; 341183 min*ng/mL
Phase 4 N=200 Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
Transplant; Failure, Kidney
Primary: Incidence of Acute Rejection at One Year Post-transplant — 14; 13 percentage of patients having BPAR
Phase 2 N=9 Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
Male Pattern Hair Loss · Androgenetic Alopecia
Primary: Percent Change in Target Area Total Hair Count — -2.6; 27.4; 4.9; -5.8 percentage change in total hair count
Phase 1 N=32 Food and Insulin Effect on QT/QTC Interval of ECG
Effects of Different Meals on the QT/QTc Interval · Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use · C-Peptide Effects on the QT/QTc Interval
Primary: The Effect of Food (Fasted and Fed State) on the Degree of QT Prolongation Caused by Moxifloxacin — 14.4; 11.6 ms — p=0.05
N/A N=252 A Prospective, Multicenter Observational Study on MAST™ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
Degenerative Lumbar Spine Causing Back and/or Leg Pain · Lumbar Spine Degeneration
Primary: Time From Surgery to First Ambulation. — 1.3 Days from surgery to first ambulation
Phase 2 N=65 Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
Adenocarcinoma of the Gastroesophageal Junction · Esophageal Cancer
Primary: Number of Participants With Pathologic Complete Response Following Surgery — 18 participants
Phase 2 N=141 A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer
Breast Cancer
Primary: Progression-Free Survival (PFS) — 4.4; 4.1 months
Phase 3 N=108 A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment
Luteal Hormone Supplementation
Primary: The Proportion of Subjects With Blood Progesterone Concentration Not Less Than 10 ng/ml — 98.9 percentage of subjects
Phase 2 N=25 Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
HIV-1 Infection · HIV Infections
Primary: Percentage of Participants With Plasma HIV-1 RNA >50 — 12.5 percentage of participants
Phase 4 N=137 The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI
Infertility
Primary: Pregnancy Rate — 64.7; 57.8; 32.4 percentage of pregnant participants
N/A N=1,638 Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Breast Cancer
Primary: Cancer Detection Rate Per 1000 Women Screened, by Breast Density — 3.2; 12.0; 10.7; 0 cancers per 1000 women screened — p=<0.001
N/A N=50 Comparative Study of Two Marketed 1-day Soft Contact Lenses
Myopia
Primary: Lens Fit - Decentration After Insertion — 0.12; 0.07; -0.11; -0.15 mm
Phase 4 N=62 Hypertonic Saline for Acute Bronchiolitis
Bronchiolitis, Viral · Saline Solution, Hypertonic
Primary: Respiratory Assessment Change Score (RACS) — -1.5; -4 units on a scale — p=0.01